• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用英国生物银行参与者的医疗保健数据分析长期体重指数轨迹与2型糖尿病和动脉粥样硬化性心血管疾病风险的关系

Long-term body mass index trajectories and the risk of type 2 diabetes mellitus and atherosclerotic cardiovascular disease using healthcare data from UK Biobank participants.

作者信息

Krüger Anja, Willems van Dijk Ko, van Heemst Diana, Noordam Raymond

机构信息

Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands.

Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands; Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands.

出版信息

Atherosclerosis. 2025 Apr;403:119135. doi: 10.1016/j.atherosclerosis.2025.119135. Epub 2025 Feb 20.

DOI:10.1016/j.atherosclerosis.2025.119135
PMID:39999659
Abstract

BACKGROUND AND AIMS

Most epidemiological studies ignore long-term burden, gain and variability in body weight in assessing cardiometabolic disease risk. We investigated the associations of body mass index (BMI) trajectories measured by general practitioners with incident type 2 diabetes (T2D) and coronary artery disease (CAD).

METHODS

We used electronic healthcare data from 111,615 European-ancestry participants from UK Biobank (57.1 (SD 7.8) years, 59.6 % women) with at least three BMI measurements (median trajectory period: 14.9 [interquartile range 9.5, 20.1] years). We calculated six variables capturing different long-term aspects, including i.e. burden (long-term average, area under the curve), gain (slope) and variability (standard deviation, average of the [absolute] consecutive BMI differences). The variables were used in principal component (PC) analyses and k-means clustering. Newly-derived dimensions and subgroups were used as exposures in cox-proportional hazard models.

RESULTS

The BMI-trajectory indices were captured in two PCs reflecting BMI burden and BMI gain. The BMI-burden PC associated with higher T2D (hazard ratio [95 % confidence interval] per SD higher PC: 1.57 [1.55,1.60]) and CAD (1.17 [1.15,1.19]) risks, while weak or no associations were observed with the BMI-gain PC (T2D: 1.03 [1.01,1.05]; CAD: 1.01 [0.98,1.03]). Participants with the highest BMI burden, compared to those with lowest BMI burden without significant gain, had highest T2D (6.96 [6.41,7.55]) and CAD (1.57 [1.45,1.69]) risks. Both methods to capture BMI burden, gain and variability showed superior model fit compared to a single baseline BMI assessment.

CONCLUSIONS

Long-term high BMI burden, irrespective of BMI gain, was a risk factor for cardiometabolic disease.

摘要

背景与目的

大多数流行病学研究在评估心血管代谢疾病风险时忽略了体重的长期负担、增加量及变异性。我们调查了全科医生测量的体重指数(BMI)轨迹与2型糖尿病(T2D)和冠状动脉疾病(CAD)发病之间的关联。

方法

我们使用了来自英国生物银行的111615名欧洲血统参与者的电子医疗数据(年龄57.1[标准差7.8]岁,女性占59.6%),这些参与者至少有三次BMI测量值(中位轨迹期:14.9[四分位间距9.5,20.1]年)。我们计算了六个变量,以反映不同的长期情况,包括负担(长期平均值、曲线下面积)、增加量(斜率)和变异性(标准差、[绝对]连续BMI差值的平均值)。这些变量用于主成分(PC)分析和k均值聚类。新得出的维度和亚组用作Cox比例风险模型中的暴露因素。

结果

BMI轨迹指数在反映BMI负担和BMI增加量的两个主成分中得以体现。BMI负担主成分与更高的T2D风险(每标准差更高的主成分的风险比[95%置信区间]:1.57[1.55,1.60])和CAD风险(1.17[1.15,1.19])相关,而与BMI增加量主成分的关联较弱或无关联(T2D:1.03[1.01,1.05];CAD:1.01[0.98,1.03])。与BMI负担最低且无显著增加的参与者相比,BMI负担最高的参与者患T2D(6.96[6.41,7.55])和CAD(1.57[1.45,1.69])的风险最高。与单一的基线BMI评估相比,两种捕捉BMI负担、增加量和变异性的方法均显示出更好的模型拟合度。

结论

无论BMI增加情况如何,长期高BMI负担都是心血管代谢疾病的一个危险因素。

相似文献

1
Long-term body mass index trajectories and the risk of type 2 diabetes mellitus and atherosclerotic cardiovascular disease using healthcare data from UK Biobank participants.利用英国生物银行参与者的医疗保健数据分析长期体重指数轨迹与2型糖尿病和动脉粥样硬化性心血管疾病风险的关系
Atherosclerosis. 2025 Apr;403:119135. doi: 10.1016/j.atherosclerosis.2025.119135. Epub 2025 Feb 20.
2
Association of a composite trait for anthropometrics, adiposity and energy expenditure with cardiometabolic diseases: An age-stratified cohort and genetic risk score analysis.复合表型与人体测量学、肥胖和能量消耗与心血管代谢疾病的关联:年龄分层队列和遗传风险评分分析。
Diabetes Obes Metab. 2024 Dec;26(12):5922-5930. doi: 10.1111/dom.15966. Epub 2024 Oct 2.
3
Evaluation of a machine learning-based metabolic marker for coronary artery disease in the UK Biobank.在英国生物银行中基于机器学习的冠状动脉疾病代谢标志物评估。
Atherosclerosis. 2025 Feb;401:119103. doi: 10.1016/j.atherosclerosis.2024.119103. Epub 2024 Dec 18.
4
Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies.体重指数与伴有和不伴有心血管代谢疾病的成年人的癌症风险:来自 EPIC 和 UK Biobank 前瞻性队列研究的证据。
BMC Med. 2023 Nov 23;21(1):418. doi: 10.1186/s12916-023-03114-z.
5
Joint and interactive associations of body mass index and genetic factors with cardiovascular disease: a prospective study in UK Biobank.体重指数和遗传因素与心血管疾病的联合和交互关联:英国生物库的前瞻性研究。
BMC Public Health. 2024 Sep 2;24(1):2371. doi: 10.1186/s12889-024-19916-6.
6
Childhood maltreatment, adulthood obesity and incident type 2 diabetes: a retrospective cohort study using UK Biobank.儿童期虐待、成年期肥胖与2型糖尿病发病:一项使用英国生物银行的回顾性队列研究
Int J Obes (Lond). 2025 Jan;49(1):140-146. doi: 10.1038/s41366-024-01652-x. Epub 2024 Oct 15.
7
Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study.英国生物库中体重指数与心脏代谢疾病的关联:一项孟德尔随机化研究。
JAMA Cardiol. 2017 Aug 1;2(8):882-889. doi: 10.1001/jamacardio.2016.5804.
8
Association of coffee consumption with cardiometabolic multimorbidity: A prospective cohort study in the UK biobank.咖啡摄入与心脏代谢性多种疾病的关联:英国生物库中的前瞻性队列研究。
Nutr Metab Cardiovasc Dis. 2024 Dec;34(12):2779-2788. doi: 10.1016/j.numecd.2024.08.004. Epub 2024 Aug 8.
9
Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study.2 型糖尿病患者的冠状动脉钙、肝脂肪变性和动脉粥样硬化性心血管疾病风险:达拉斯心脏研究的结果。
Prog Cardiovasc Dis. 2023 May-Jun;78:67-73. doi: 10.1016/j.pcad.2023.03.002. Epub 2023 Mar 15.
10
Hemoglobin A1c and abdominal obesity as predictors of diabetes and ASCVD in individuals with prediabetes in UK Biobank: a prospective observational study.血红蛋白A1c和腹型肥胖作为英国生物银行中糖尿病前期个体发生糖尿病和动脉粥样硬化性心血管疾病的预测因素:一项前瞻性观察研究。
Cardiovasc Diabetol. 2024 Dec 19;23(1):448. doi: 10.1186/s12933-024-02525-3.